These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Association between clustering of cardiovascular risk factors and the risk of cardiovascular disease]. Baena Díez JM; Alvarez Pérez B; Piñol Forcadell P; Martín Peñacoba R; Nicolau Sabaté M; Altès Boronat A Rev Esp Salud Publica; 2002; 76(1):7-15. PubMed ID: 11905401 [TBL] [Abstract][Full Text] [Related]
27. Effects of smoking on serum lipid and lipoprotein concentrations and lecithin: cholesterol acyltransferase activity. Dirican M; Sarandöl E; Ulukaya E; Tokullugil HA J Med Invest; 1999 Aug; 46(3-4):169-72. PubMed ID: 10687311 [TBL] [Abstract][Full Text] [Related]
28. The association of dyslipoproteinemia with symptoms and signs of peripheral arterial disease. The Lipid Research Clinics Program Prevalence Study. Pomrehn P; Duncan B; Weissfeld L; Wallace RB; Barnes R; Heiss G; Ekelund LG; Criqui MH; Johnson N; Chambless LE Circulation; 1986 Jan; 73(1 Pt 2):I100-7. PubMed ID: 3940676 [TBL] [Abstract][Full Text] [Related]
29. Vascular risk factors in the obliterative peripheral arteriopathy of diabetic patients. Fekete T; Mösler R; Panduru V Med Interne; 1985; 23(1):23-8. PubMed ID: 3992144 [TBL] [Abstract][Full Text] [Related]
30. [The effect of vascular risk factors in arteriopathy of the legs in women]. Boissier C; Carpentier P; Conchonnet P; Ellison W; Lance G; Mollard JM J Mal Vasc; 1990; 15(3):296-302. PubMed ID: 2212879 [TBL] [Abstract][Full Text] [Related]
31. An attempt to establish early signals of peripheral arterial disease (PAD): the use of rhythm's parameters of peripheral blood flow (RF). Tarquini B; Cinelli P; Buffoni M; de Cristofaro R; Benvenuti M; Romano S; Cagnoni M Chronobiologia; 1982; 9(3):321-6. PubMed ID: 7172871 [TBL] [Abstract][Full Text] [Related]
32. [Risk status of patients with peripheral arterial disease (PAD)]. Jassó I; Landi A; Dinya E Orv Hetil; 2007 Dec; 148(52):2469-76. PubMed ID: 18079094 [TBL] [Abstract][Full Text] [Related]
33. [Effect of calciparine in the mid-term treatment of peripheral arteriopathy of the lower extremities]. Stanzani M; Colombo L; Altomare S; Pagnozzi G; Barbieri C; Bruschi R; Pietrasanta E Minerva Cardioangiol; 1993 Oct; 41(10):465-8. PubMed ID: 8302443 [TBL] [Abstract][Full Text] [Related]
35. Lipoprotein(a) and general risk factors in patients with angiographically assessed peripheral arterial disease. Prior M; Arosio E; Ferrari M; Lucchese L; Guidi GC; Bosello O Int Angiol; 1995 Dec; 14(4):357-63. PubMed ID: 8708427 [TBL] [Abstract][Full Text] [Related]
36. [On the behavior of lipidemia, blood viscosity and arterial flow of the limbs after oral lipid loading. Observations in subjects with peripheral obliterating arteriopathies]. Bartoli V; Dorigo B; Ponzeveroni A; Barletta O Mal Cardiovasc; 1969; 10(4):651-62. PubMed ID: 5405783 [No Abstract] [Full Text] [Related]
39. "Risk factors" and manifestations of arteriosclerosis in patients with intermittent claudication compared to normal persons. Jacobsen UK; Dige-Pedersen H; Gyntelberg F; Svendsen UG Dan Med Bull; 1984 Apr; 31(2):145-8. PubMed ID: 6723377 [No Abstract] [Full Text] [Related]
40. [Carbohydrate and lipid metabolism in normal subjects and patients with peripheral arterial occlusive diseases. Effect of stamina training]. Diehm C Vasa Suppl; 1984; 13():1-61. PubMed ID: 6595880 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]